types of glp-1 receptor agonists for individualized treatment type 2 diabetes mellitus The Impact of GLP-1 Receptor
Description
Background: The evidence on berberine stimulating the secretion of GLP-1 in intestinal L cell has been studied
The science, promise and clinical development of GLP-1 and GIP receptor agonists in obesity
The incretin pathway is a self-regulating feedback system connecting the gut with the brain, pancreas, and liver
Glucagon-like peptide-1 receptor agonist (GLP-1RA), a novel hypoglycemic agent for the treatment of type 2 diabetes, has well-known effects such as lowering ...
However, there was no significant difference in adverse CVEs or all-cause mortality when compared with those taking SGLT2 inhibitors
This study investigated the potential association between GLP-1RAs and SSIBs by exploring the FDA Adverse Event Reporting System (FAERS) database
